CDC Monitoring Marburg Virus Outbreak in Rwanda, Risk to U.S. Remains Low
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak of Marburg virus disease in Rwanda, where 26 cases, including eight deaths, have been confirmed by the Republic of Rwanda Ministry of Health. While the situation is concerning, the CDC states the risk to the general public in the United States remains low. The agency is providing support to Rwandan health officials to contain the spread of this highly virulent disease, which is similar to Ebola.
Marburg virus disease is a severe and often fatal illness characterized by hemorrhagic fever. It’s transmitted to people through contact with infected bats and from person-to-person through direct contact with bodily fluids of infected individuals. Healthcare workers are particularly vulnerable due to the nature of their work. Early symptoms can include fever, rash, and eventually, severe bleeding. The current outbreak underscores the importance of robust public health infrastructure and rapid response capabilities, areas where the CDC has been collaborating with Rwanda for over two decades.
Longstanding Partnership Aids Response Efforts
The CDC has maintained a presence in Rwanda since 2002, operating an office dedicated to strengthening the country’s health systems and bolstering its ability to prevent and respond to infectious disease outbreaks. This longstanding partnership has been instrumental in building local capacity, including the training of epidemiologists through the Field Epidemiology Training Program (FETP). The FETP equips Rwandan scientists with the skills necessary to investigate and manage outbreaks effectively. CDC’s Rwanda office plays a critical role in these efforts.
Beyond outbreak response, the CDC has collaborated with Rwanda on major global health initiatives, including the President’s Emergency Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative (PMI), jointly implemented with USAID. These programs have significantly strengthened Rwanda’s overall health infrastructure, creating a foundation that is now proving valuable in addressing the Marburg outbreak. The CDC’s coordination extends across the U.S. Government, involving collaboration with the U.S. Ambassador to Rwanda and their team.
Immediate Support Deployed to Rwanda
In response to the outbreak, the CDC is deploying a team of subject matter experts to Rwanda. These experts will provide on-the-ground assistance with epidemiological investigations, contact tracing, laboratory testing, and the implementation of infection prevention and control measures in healthcare settings. The team will leverage their experience responding to similar outbreaks in other countries to support Rwanda’s efforts. This support includes strengthening border surveillance and enhancing hospital preparedness.
The Ministry of Health in Rwanda first announced the outbreak on September 22, 2024, and has been providing regular updates on the situation. The Ministry’s X (formerly Twitter) account has been a key source of information, sharing details on confirmed cases and preventative measures. The CDC is working closely with the Ministry to verify information and coordinate response activities.
Understanding Marburg Virus Disease
Marburg virus disease is caused by the Marburg virus, a member of the filovirus family, which also includes Ebola virus. The virus is naturally carried by certain species of fruit bats. Human infection typically begins with exposure to these bats or contact with infected animals, such as monkeys or pigs. Once transmitted to a human, the virus can spread through direct contact with bodily fluids – blood, urine, saliva, sweat, feces, vomit, and semen – from infected individuals.
Symptoms of Marburg virus disease typically appear within 2-21 days of infection and can include fever, severe headache, muscle aches, weakness, and vomiting. As the disease progresses, patients may experience diarrhea, abdominal pain, and bleeding from various sites. There is currently no approved vaccine or specific treatment for Marburg virus disease, but supportive care – including rehydration, symptom management, and preventing secondary infections – can improve survival rates. The CDC provides detailed information on Marburg virus disease, including prevention measures and guidance for healthcare professionals.
What Which means for the United States
While the outbreak in Rwanda is a serious concern, the CDC emphasizes that the risk to the U.S. Public remains low. There have been no reported cases of Marburg virus disease in the United States related to this outbreak. The CDC continues to monitor the situation closely and is prepared to respond should any cases emerge. Travelers returning from affected areas are advised to monitor their health and seek medical attention if they develop any symptoms consistent with Marburg virus disease.
The CDC is also working with international partners, including the World Health Organization (WHO), to support the global response to the outbreak. This collaborative effort is crucial to containing the spread of the virus and preventing further infections.
The CDC will provide updates as the situation evolves and latest information becomes available. The next scheduled update from the CDC regarding the Rwanda outbreak is expected on October 7, 2024.
Have questions or concerns? Share your thoughts in the comments below, and please share this article to help keep your community informed.
